Showing 1 - 6 results of 6 for search 'Bernhard H. Weigl', query time: 0.03s Refine Results
  1. 1
    Analytical Tools to Improve Optimization Procedures for Lateral Flow Assays

    Analytical Tools to Improve Optimization Procedures for Lateral Flow Assays by Helen V. Hsieh, Jeffrey L. Dantzler, Bernhard H. Weigl

    Published 2017-05-01
    Get full text
    Article
  2. 2
    A SARS-CoV-2 coronavirus nucleocapsid protein antigen-detecting lateral flow assay

    A SARS-CoV-2 coronavirus nucleocapsid protein antigen-detecting lateral flow assay by Benjamin D. Grant, Caitlin E. Anderson, Luis F. Alonzo, Spencer H. Garing, John R. Williford, Ted A. Baughman, Rafael Rivera, Veronika A. Glukhova, David S. Boyle, Puneet K. Dewan, Bernhard H. Weigl, Kevin P. Nichols

    Published 2021-01-01
    Get full text
    Article
  3. 3
    A SARS-CoV-2 coronavirus nucleocapsid protein antigen-detecting lateral flow assay.

    A SARS-CoV-2 coronavirus nucleocapsid protein antigen-detecting lateral flow assay. by Benjamin D Grant, Caitlin E Anderson, Luis F Alonzo, Spencer H Garing, John R Williford, Ted A Baughman, Rafael Rivera, Veronika A Glukhova, David S Boyle, Puneet K Dewan, Bernhard H Weigl, Kevin P Nichols

    Published 2021-01-01
    Get full text
    Article
  4. 4
    Field evaluation of a prototype paper-based point-of-care fingerstick transaminase test.

    Field evaluation of a prototype paper-based point-of-care fingerstick transaminase test. by Nira R Pollock, Sarah McGray, Donn J Colby, Farzad Noubary, Huyen Nguyen, The Anh Nguyen, Sariah Khormaee, Sidhartha Jain, Kenneth Hawkins, Shailendra Kumar, Jason P Rolland, Patrick D Beattie, Nguyen V Chau, Vo M Quang, Cori Barfield, Kathy Tietje, Matt Steele, Bernhard H Weigl

    Published 2013-01-01
    Get full text
    Article
  5. 5
    Clinical validation of an open-access SARS-COV-2 antigen detection lateral flow assay, compared to commercially available assays.

    Clinical validation of an open-access SARS-COV-2 antigen detection lateral flow assay, compared to commercially available assays. by Christine M Bachman, Benjamin D Grant, Caitlin E Anderson, Luis F Alonzo, Spencer Garing, Sam A Byrnes, Rafael Rivera, Stephen Burkot, Alexey Ball, James W Stafford, Wenbo Wang, Dipayan Banik, Matthew D Keller, David M Cate, Kevin P Nichols, Bernhard H Weigl, Puneet Dewan

    Published 2021-01-01
    Get full text
    Article
  6. 6
    Screening Antibodies Raised against the Spike Glycoprotein of SARS-CoV‑2 to Support the Development of Rapid Antigen Assays

    Screening Antibodies Raised against the Spike Glycoprotein of SARS-CoV‑2 to Support the Development of Rapid Antigen Assays by Jason L. Cantera, David M. Cate, Allison Golden, Roger B. Peck, Lorraine L. Lillis, Gonzalo J. Domingo, Eileen Murphy, Bryan C. Barnhart, Caitlin A. Anderson, Luis F. Alonzo, Veronika Glukhova, Gleda Hermansky, Brianda Barrios-Lopez, Ethan Spencer, Samantha Kuhn, Zeba Islam, Benjamin D. Grant, Lucas Kraft, Karine Herve, Valentine de Puyraimond, Yuri Hwang, Puneet K. Dewan, Bernhard H. Weigl, Kevin P. Nichols, David S. Boyle

    Published 2021-07-01
    Get full text
    Article

Search Tools: